New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Eli Lilly and Company

LLY

Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.

Revenue
+38.6%
EPS
+16.3%
Free cash flow
+21.8%
Total debt
+15.0%

Quarter to September 2026, against a year earlier

1,352.05 0.40 +0.03%
Market cap
$1.27T
P/E
43.9×
Fwd P/E FY26e
42.2×
Dividend yield
0.51%
F-score
7/9
ROIC
26.4%
Net debt / EBITDA
1.2×
Payout ratio
0.2×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $33.6B more in debt than it holds in cash and short-term investments. Debt has risen from $10.3B to $40.9B since FY16. Shareholders’ equity is 23.6% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $112.5B

Owns

$56.8BLong-term assets
$48.4BOther short-term assets
$7.3BCash & short-term investments

Funded by

$26.5BShareholders’ equity
$45.1BOther liabilities
$40.9BDebt

Debt is 36.3% of the total; shareholders’ equity 23.6%.

Net debt rose from 11% of assets to 30% since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$38.8B$45.0B$43.9B$39.3B$46.6B$48.8B$49.5B$64.0B$78.7B$112.5B
Net debt (debt less cash)$4.3B$5.6B$2.9B$13.0B$12.9B$11.4B$12.5B$15.4B$25.3B$33.6B
Net debt ÷ assets (right axis)11.0%12.5%6.6%33.1%27.7%23.4%25.3%24.0%32.1%29.9%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
15,101.40 19,202.10 20,549.60 13,709.60 17,462.10 18,452.40 18,034.50 25,727.00 32,740.00 55,629.00
Total non-current assets
23,704.50 25,778.90 23,358.80 25,576.50 29,171.00 30,353.60 31,455.30 38,279.30 45,975.00 56,847.00
Total Assets
38,805.90 44,981.00 43,908.40 39,286.10 46,633.10 48,806.00 49,489.80 64,006.30 78,715.00 112,476.00
Total current liabilities
10,986.60 14,535.90 11,888.10 11,775.20 12,481.60 15,052.70 17,138.20 27,293.20 28,376.00 35,228.00
Total non-current liabilities
13,738.80 18,777.20 21,111.20 24,811.80 28,326.30 24,598.50 21,576.20 25,849.40 36,067.00 50,713.00
Total liabilities
24,725.40 33,313.10 32,999.30 36,587.00 40,807.90 39,651.20 38,714.40 53,142.60 64,443.00 85,941.00
Common Equity (Total)
14,080.50 11,667.90 10,909.10 2,699.10 5,825.20 9,154.80 10,775.40 10,863.70 14,272.00 26,535.00
Shareholders Equity (Total)
14,080.50 11,667.90 10,909.10 2,699.10 5,825.20 9,154.80 10,775.40 10,863.70 14,272.00 26,535.00
Total Debt
10,304.80 13,647.50 10,298.40 15,438.90 16,595.30 15,346.40 14,737.50 18,320.80 28,527.00 40,868.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026